SEC Form 4 · accession 0001145443-16-001604
ALBIREO PHARMA, INC. · ALBO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel Lorber
Director
Period of report
Feb 24, 2016
Accepted (ET)
Mar 8, 2016 · 5:54 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001322505
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $0.30 | Feb 24, 2016 | A | 100,000 | A | — | Feb 23, 2023 | Common Stock | 100,000 | 100,000 | D |
Explanation of responses
- F1The option will vest in 12 equal monthly installments on the last day of each month beginning on the date of grant.